I-Mab Other Current Liabilities

The latest other current liabilities for IMAB is $6.5M as of June 2025. That compares with $13M in the prior-year period — down 50.9% year over year. Investors often review this figure alongside I-Mab's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMAB's other current liabilities moved from $13M to $6.5M — a 50.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in I-Mab's operating scale or balance-sheet position.

A other current liabilities figure of $6.5M for IMAB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMAB's other current liabilities ($6.5M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack I-Mab's other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.